Processa Pharmaceuticals, Inc. (PCSA)
Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States. The company's leading investigational drug, PCS499, is an oral tablet presently undergoing Phase 2B clinical assessment. It aims to treat both ulcerative and non-ulcerative manifestations of necrobiosis lipoidica, a chronic and disfiguring dermatological condition. Processa's portfolio also features PCS12852, a unique selective 5-hydroxytryptamine 4 (5-HT4) receptor agonist. This compound is currently in Phase 2A clinical trials for its potential application in managing gastroparesis, chronic constipation, constipation-predominant irritable bowel syndrome, and functional dyspepsia. Furthermore, the firm is advancing PCS3117, a cytosine analog, which has reached Phase 2B clinical trials for its use in pancreatic cancer and non-small cell lung cancer. Another candidate, PCS6422, an oral, potent, selective, and irreversible inhibitor of dihydropyrimidine dehydrogenase, is progressing through Phase 1B clinical trials for metastatic colorectal and breast cancers. In addition, Processa is developing PCS11T, an analog derived from the drugs SN38 and irinotecan, intended for the treatment of diverse cancer types. The company was founded in 2011 and maintains its corporate headquarters in Hanover, Maryland.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Processa Pharmaceuticals, Inc.
NASDAQ:PCSAHealthcare · Biotechnology
+0.00%$1.89
Mkt Cap$5.28M
Float2.33M
O/S2.79M
Vol
$ Vol
RVOL
Inst Own9.1%
SI2.0%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$13.56M
Total Assets$7.81M
Free Cash Flow-$11.39M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$5.58M
Shares Outstanding
Short Interest
Split History5 splits · 5 reverse
2-year cumulative
1:25
Nasdaq bars a compliance period at 1:250
- 1:25Reverse splitDec 17, 202525 shares → 1
- 1:20Reverse splitJan 22, 202420 shares → 1
- 1:7Reverse splitDec 23, 20197 shares → 1
- 1:7Reverse splitDec 8, 20177 shares → 1
- 1:5Reverse splitFeb 17, 20045 shares → 1
Balance Sheet Details
Assets$7.81M
Liabilities$2.24M
Accounts Receivable$0
Accounts Payable$1.06M
Inventory$0
PP&E (Net)$4K
Goodwill$0
Intangible Assets$1.15M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5K | $113K | $200K | $312K | $192K | $20K | $140K |
| YoY Growth | - | - | - | - | - | - | - | - | - | -95.6% | -43.3% | -35.9% | 62.6% | 860.7% | -85.7% | - |
| Cost of Revenue | $0 | $0 | $0 | $874K | $0 | $882K | $0 | $0 | $0 | $1K | $126K | $113K | $188K | $133K | $525 | $150K |
| Gross Profit | $0 | $0 | $0 | -$874K | $0 | -$882K | -$878K | -$630K | -$2K | $4K | -$12K | $87K | $124K | $59K | $20K | -$10K |
| Gross Margin | - | - | - | - | - | - | - | - | - | 72.4% | -11.0% | 43.4% | 39.8% | 30.6% | 100.0% | -7.1% |
| Research and Development | $7.81M | $7.27M | $5.8M | $10.71M | $6.88M | $11.08M | $2.32M | $3.09M | $926K | $7K | $29K | $190K | $267K | $448K | $170K | $110K |
| Selling, General, and Administrative | $6.18M | $4.78M | $5.66M | $8.68M | $4.69M | $3.18M | $1.61M | $1.44M | $876K | $385K | $945K | $1.59M | $2.82M | $1.88M | $610K | $40K |
| Other | $0 | $0 | $0 | $0 | $567K | $0 | $0 | $0 | $0 | $1.85M | $0 | $0 | $0 | $0 | $10K | $0 |
| Total Operating Expenses | $13.99M | $12.05M | $11.46M | $19.38M | $12.13M | $14.25M | $3.94M | $4.52M | $1.8M | $1.93M | $975K | $3.03M | $3.09M | $2.33M | $790K | $150K |
| Operating Income (EBIT) | -$13.99M | -$12.05M | -$11.46M | -$20.26M | -$12.13M | -$15.14M | -$3.94M | -$4.52M | -$1.8M | -$1.92M | $2.69M | -$4.16M | -$2.96M | -$2.27M | -$770K | -$160K |
| Operating Margin | - | - | - | - | - | - | - | - | - | -38430.4% | 2372.6% | -2078.1% | -947.7% | -1182.8% | -3850.0% | -114.3% |
| Interest Expense | $0 | $0 | $0 | $0 | $362 | $281K | $37K | $161K | $36K | $245K | $236K | $315K | $110K | $171K | -$170K | $0 |
| Interest Income | $109K | $201K | $336K | $101K | $12K | $3K | $12K | $18K | $5K | $0 | $5K | $155 | $2K | $3K | $0 | $0 |
| Other Income (Expense) | $425K | $201K | $336K | -$7.17M | $175K | -$278K | -$25K | -$143K | -$54K | $4K | -$5.67M | $0 | -$107K | -$168K | -$170K | $0 |
| Income Before Tax (EBT) | -$13.56M | -$11.85M | -$11.12M | -$27.42M | -$11.96M | -$15.41M | -$3.96M | -$4.67M | -$1.86M | -$337K | -$2.98M | -$3.69M | -$3.07M | -$2.44M | -$940K | -$160K |
| Income Tax Expense | $0 | $0 | $0 | $0 | -$531K | -$1M | -$603K | -$903K | -$18K | -$1K | $100 | $100 | $50 | $181 | $0 | $0 |
| Net Income | -$13.56M | -$11.85M | -$11.12M | -$27.42M | -$11.43M | -$19.04M | -$3.36M | -$3.77M | -$1.86M | -$336K | -$3.35M | -$4.53M | -$3.07M | -$2.44M | -$940K | -$160K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | -6719.6% | -2957.2% | -2260.9% | -982.0% | -1270.2% | -4700.0% | -114.3% |
| Supplementary Data | ||||||||||||||||
| EPS | -10.36 | -96.75 | -212.00 | -851.19 | -373.00 | -1269.25 | -304.25 | -355.00 | -200.00 | -747.25 | -7460.00 | -16660.00 | -14945.00 | -16917.25 | -510.00 | -85.00 |
| Diluted EPS | -10.36 | -96.75 | -212.00 | -851.19 | -373.00 | -1269.25 | -304.25 | -355.00 | -200.00 | -747.25 | -7460.00 | -16660.00 | -14945.00 | -16917.25 | -510.00 | -85.00 |
| Weighted Average OS | 1.31M | 122,396 | 52,463 | 32,219 | 30,639 | 14,999 | 11,051 | 10,664 | 9,313 | 1,197 | 0 | 0 | 0 | 402 | 112 | 320 |
| EBITDA | -$13.56M | -$11.85M | -$11.12M | -$26.64M | -$10.78M | -$14.33M | -$3.12M | -$3.88M | -$1.8M | -$90K | -$2.51M | -$2.94M | -$2.54M | -$2.16M | -$768K | -$160K |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | -1808.3% | -2211.5% | -1469.5% | -814.1% | -1124.8% | -3842.4% | -114.3% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
| Assets | ||||||||||||||||
| Current Assets | ||||||||||||||||
| Cash and Cash Equivalents | $5.54M | $1.19M | $4.71M | $6.5M | $16.5M | $15.42M | $692K | $1.74M | $2.85M | $3K | $2K | $21K | $187K | $1.03M | $2.79M | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $5.54M | $1.19M | $4.71M | $6.5M | $16.5M | $15.42M | $692K | $1.74M | $2.85M | $3K | $2K | $21K | $187K | $1.03M | $2.79M | $0 |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $232K | $0 | $22K | $63K | $0 | $0 | $1K | $19K | $30K | $10K | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $219K | $228K | $49K | $0 | $0 |
| Other Current Assets | $0 | $0 | $926K | $0 | $70K | $0 | $0 | $0 | $0 | $0 | $54K | $0 | $0 | -$6K | $0 | $0 |
| Total Current Assets | $5.67M | $1.87M | $5.63M | $8.39M | $18.33M | $16.2M | $1.01M | $2.02M | $2.95M | $3K | $104K | $379K | $515K | $1.16M | $2.8M | $0 |
| Long-Term Assets | ||||||||||||||||
| Property, Plant & Equipment Net | $4K | $76K | $149K | $228K | $74K | $159K | $228K | $17K | $26K | $22K | $159 | $466K | $370K | $316K | $1K | $20K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $1.15M | $0 | $0 | $0 | $8.06M | $8.85M | $9.64M | $10.44M | $0 | $0 | $0 | $1.7M | $2.05M | $2.41M | $2.5M | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | -$1.9M | -$1.12M | $1.8M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.9M | $1.12M | $734K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $994K | $1.28M | $6K | $6K | $6K | $6K | $6K | -$2.53M | $6K | $6K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $2.14M | $1.36M | $154K | $233K | $8.14M | $9.01M | $9.88M | $10.46M | $31K | $28K | $159 | $2.16M | $2.42M | $2.73M | $2.5M | $20K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $734K | $0 | -$28K | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $7.81M | $3.23M | $5.79M | $8.62M | $26.46M | $25.21M | $10.88M | $13.21M | $2.98M | $3K | $104K | $2.54M | $2.94M | $3.88M | $5.31M | $20K |
| Liabilities | ||||||||||||||||
| Current Liabilities | ||||||||||||||||
| Accounts Payable | $1.06M | $881K | $312K | $328K | $219K | $321K | $76K | $292K | $51K | $166K | $159K | $154K | $77K | $73K | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $118K | $803K | $230K | $2.45M | $1.61M | $1.37M | $466K | $631K | $527K | $300K | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $200 | $200 | $100 | $100 | $150 | $100 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $484K | $0 | $58K | $0 | $150 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $189K | $189K | $402K | $470K | $316 | $0 | $436 | $0 | $557K | $59K | $155K | $0 | $0 | $0 |
| Total Current Liabilities | $2.24M | $1.53M | $731K | $999K | $971K | $1.22M | $1.19M | $646K | $2.6M | $98K | $2.08M | $840K | $1.12M | $716K | $331K | $0 |
| Long-Term Liabilities | ||||||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $45K | $0 | $0 | $0 | $0 | $0 | $494K | $145K | $606K | $2.2M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | -$2K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $531K | $1.53M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | -$0 | $0 | $0 | $0 | $0 | $400K | $0 | $2.13M | $10K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | -$0 | $487 | $67K | $151K | $7K | $1.05M | $1.68M | $2.13M | $10K | $0 | $0 | $494K | $145K | $606K | $2.2M | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.24M | $1.53M | $797K | $1.15M | $978K | $2.27M | $2.87M | $3.51M | $2.61M | $2.35M | $2.08M | $1.33M | $1.27M | $1.32M | $2.53M | $0 |
| Stockholders' Equity | ||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.8M | $0 | $18 | $18 | $18 | $101 | $286 | $210 | $0 |
| Common Stock | $257 | $371 | $129 | $2K | $2K | $1K | $549 | $4K | $4K | $1K | $1K | $1K | $808 | $190 | $280 | $0 |
| Retained Earnings | -$100.78M | -$87.22M | -$75.37M | -$64.25M | -$36.82M | -$25.4M | -$10.98M | -$7.62M | -$3.86M | -$15.25M | -$14.87M | -$11.85M | -$6.81M | -$3.43M | -$941K | $0 |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$1.8M | -$3K | -$19K | -$19K | $0 | $0 | -$19K | -$178 | $0 |
| Other Stockholders' Equity | $106.36M | $88.91M | $80.36M | $71.72M | $62.31M | $48.33M | $18.99M | $17.32M | $4.23M | $12.9M | $12.89M | $13.06M | $8.48M | $5.99M | $3.72M | $20K |
| Total Equity | $5.58M | $1.7M | $4.99M | $7.47M | $25.49M | $22.94M | $8.01M | $9.7M | $373K | -$2.35M | -$1.98M | $1.21M | $1.67M | $2.56M | $2.78M | $20K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $7.81M | $3.23M | $5.79M | $8.62M | $26.46M | $25.21M | $10.88M | $13.21M | $2.98M | $3K | $104K | $2.54M | $2.94M | $3.88M | $5.31M | $20K |
| Supplementary Data | ||||||||||||||||
| Total Debt | $0 | $74K | $151K | $229K | $78K | $328K | $1.03M | $230K | $2.45M | $1.61M | $1.37M | $961K | $777K | $1.13M | $2.5M | $0 |
| Net Debt | -$5.54M | -$1.12M | -$4.56M | -$6.27M | -$16.42M | -$15.09M | $336K | -$1.51M | -$399K | $2K | $1.36M | $939K | $590K | $106K | -$295K | $0 |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 |
| Operating Activities | ||||||||||||||||
| Net Income | -$13.56M | -$11.85M | -$11.12M | -$27.42M | -$11.43M | -$14.41M | -$3.36M | -$3.77M | -$1.86M | -$337K | -$2.98M | -$4.53M | -$3.07M | -$2.44M | -$940K | -$160K |
| Depreciation & Amortization | $1K | $782 | $222 | $788K | $791K | $804K | $804K | $630K | $2K | $1K | $239K | $461K | $415K | $108K | $0 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | -$531K | -$1M | -$603K | -$903K | $0 | $8K | $1.54M | $1.21M | -$216K | -$453K | $0 | $0 |
| Stock-Based Compensation | $858K | $630K | $1.06M | $8.83M | $3.41M | $2.73M | $510K | $74K | $0 | $7K | $97K | $232K | $216K | $457K | $0 | $0 |
| Changes in Working Capital: | ||||||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $70K | $7K | -$77K | $0 | $0 | $0 | $0 | $213K | -$294K | $0 | $0 | -$10K | $0 |
| Inventory | $0 | $0 | $0 | $0 | -$7K | $77K | $0 | $0 | $0 | $0 | -$7K | -$77K | -$97K | -$49K | $0 | $0 |
| Accounts Payable | $176K | $569K | -$16K | $109K | -$102K | $245K | -$216K | $241K | $0 | -$10K | $5K | $84K | $4K | $73K | $0 | $0 |
| Other Working Capital | $1.37M | -$682K | $621K | $365K | -$1.08M | -$385K | $37K | -$53K | $151K | $289K | -$58K | $58K | -$8K | -$39K | $2.48M | $0 |
| Total Working Capital Change | $1.54M | -$112K | $605K | $544K | -$1.18M | -$140K | -$180K | $189K | $161K | $278K | $154K | -$228K | -$101K | -$15K | $2.47M | $0 |
| Other Non-Cash Items | -$225K | $87K | $1.39M | $7.66M | $221K | $8.88M | $76K | $67K | $39K | -$255 | $83K | $154K | $216K | $457K | -$2.24M | $0 |
| Net Cash from Operating | -$11.39M | -$11.25M | -$8.06M | -$9.61M | -$8.72M | -$3.14M | -$2.75M | -$3.71M | -$1.65M | -$43K | -$872K | -$2.7M | -$2.54M | -$1.89M | -$710K | -$160K |
| Investing Activities | ||||||||||||||||
| Capital Expenditures | -$850K | -$3K | -$3K | $0 | $0 | $0 | $0 | -$22K | -$21K | -$24K | -$1K | -$48K | -$28K | -$334K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6K | $0 | $0 | $3K | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.02M | $41K | $42K | $0 | $0 | $0 | -$2.5M | $0 |
| Net Cash from Investing | -$850K | -$3K | -$3K | $0 | $0 | $0 | $0 | -$22K | $1M | $17K | $40K | -$45K | -$28K | -$334K | -$2.5M | $0 |
| Financing Activities | ||||||||||||||||
| Debt Repaid | $7K | $5K | - | - | - | -$162K | - | - | - | - | $20K | -$1.7M | -$310K | $1.37M | -$2.5M | - |
| Common Stock Issuance | $16.6M | $7.76M | $6.32M | $0 | $10.05M | $17.1M | $0 | $2.87M | $0 | $4.27M | $88K | $366K | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | -$16K | $0 | -$389K | -$64K | -$95K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.5M | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$10K | -$9K | -$53K | -$89K | -$186K | $0 | $896K | -$251K | -$155K | $0 | $0 | $0 | $0 | $300K | -$4K | $160K |
| Net Cash from Financing | $16.58M | $7.73M | $6.27M | -$389K | $9.8M | $17.87M | $1.7M | $2.62M | $2.43M | $15K | $821K | $2.57M | $1.73M | $453K | $6M | $160K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $4.35M | -$3.51M | -$1.8M | -$9.99M | $1.08M | $14.72M | -$1.05M | -$1.11M | $1.78M | -$11K | -$11K | -$166K | -$835K | -$1.77M | $2.79M | $0 |
| Supplementary Data | ||||||||||||||||
| Operating Cash Flow | -$11.39M | -$11.25M | -$8.06M | -$9.61M | -$8.72M | -$3.14M | -$2.75M | -$3.71M | -$1.65M | -$43K | -$872K | -$2.7M | -$2.54M | -$1.89M | -$710K | -$160K |
| Capital Expenditure | -$5 | -$3K | -$3K | $3 | $0 | -$4 | $0 | -$21K | -$21K | -$24K | -$1K | -$48K | -$28K | -$334K | $0 | $0 |
| Free Cash Flow | -$11.39M | -$11.25M | -$8.07M | -$9.61M | -$8.72M | -$3.14M | -$2.75M | -$3.73M | -$1.68M | -$67K | -$873K | -$2.74M | -$2.57M | -$2.22M | -$710K | -$160K |
| Cash at Beginning | $1.19M | $4.71M | $6.5M | $16.5M | $15.42M | $692K | $1.74M | $2.85M | $1.07M | $14K | $25K | $187K | $1.02M | $2.79M | $0 | $0 |
| Cash at End | $5.54M | $1.19M | $4.71M | $6.5M | $16.5M | $15.42M | $692K | $1.74M | $2.85M | $3K | $14K | $21K | $187K | $1.03M | $2.79M | $0 |